Programme | Speaker |
---|---|
Welcome and introduction | Chair: Tadeusz Robak (Lodz, Poland) |
The burden of COVID-19 in patients with CLL | Lydia Scarfò (Milan, Italy) |
Unlocking the risk of infection in CLL with epidemiology, clinical observations and machine learning | Christian Brieghel (Copenhagen, Denmark) |
Uncovering patients’ infection risk in lymphoma and associated treatments including CAR-T cell therapy | Vincent Camus (Rouen, France) |
Real-world evidence leveraging the use of immunoglobulin replacement therapy in hematological malignancies | Fabrizio Vianello (Padua, Italy) |
Panel discussion – Q&A | All |
Closing | Tadeusz Robak (Lodz, Poland) |
EHA Congress
European Hematology Association
:quality(80)/f/54881/792x594/7f5735bbea/eha-2022-octapharma-symposium.jpg)
Join us for the 2022 edition of the European Hematology Association (EHA) Congress
Octapharma is supporting the #EHA2022 Hybrid Congress to keep the scientific community up to date on treating patients with secondary immunodeficiencies associated with hematological malignancies.
Octapharma Update-in-Hematology
Innovative approaches to reduce the infection burden in hematological malignancies
Friday 10th of June 18:00 - 19:00 CET
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.
Speakers panel
Chair: Tadeusz Robak
Copernicus Memorial Hospital
Medical University of Lodz, Poland
Lydia Scarfò
Vita-Salute San Raffaele
University of Milan, Italy
Christian Brieghel
Rigshospitalet, Copenhagen,
Denmark
Fabrizio Vianello
University of Padua,
Italy
Vincent Camus
Centre Henri Becquerel,
Rouen, France